State-certified labs typically use a technique called gas chromatography to determine residual solvents—at least they can agree on that.13 With microbial contamination, there’s no such consensus. On top of that, states do not agree on which microbial contaminants to test for in the first place or which constitute a health risk.Cannabis plants and products can pick up molds or bacteria while growing (particularly if they are grown outdoors or in a nonsanitary indoor environment) or during subsequent handling and processing.22 Most molds are relatively harmless and ubiquitous in the environment, but some may present a health threat when inhaled, particularly to immunocompromised individuals like some medical cannabis users.22Although pathogenic spores may be able to withstand combustion, some states consider mold to be a low-risk contaminant. But even in places where mold is grounds for rejecting cannabis flower, the moldy buds can still be used to produce concentrates. Image: Courtesy American Herbal Pharmacopoeia.Case in point: Aspergillus. The genus includes approximately 180 individual species of mold, many of which are very common in indoor and outdoor environments; most people breathe in Aspergillus spores every day. Even in individuals with weakened immune systems, fewer than 40 Aspergillus species are known to cause infections.23 Among those, only 4 species—A. fumigatus, A. flavus, A. niger, and A. terreus—have been singled out to date for testing on cannabis due to their association with the plant and potential health effects.22Even though pathogenic Aspergillus spores may be able to survive the heat of combustion, some states consider the risk of harm to be low enough that they do not bother testing for them. “The mold is so common in the environment that a person could pick it up many different ways,” reads a 2015 report24 detailing recommendations for Oregon’s cannabis contaminant-testing regime. “A positive test result would not mean the product is unsafe for most uses for most people.”The Oregon report recommends that, rather than testing for the four strains, the state health authority simply require that product labels carry a warning of the risk for people with suppressed immune systems. In the end, the state chose not to do even that. Instead, Oregon currently relies on a measure known as “water activity” to monitor mold and other microbial contaminants on cured flower.25 This measure, which is also used in food processing, reflects the amount of water available to microorganisms. Samples with water activity levels below a certain threshold are considered too dry for microbes to flourish and, thus, safe.Oregon’s policies are partially at odds with the recommendations of a white paper on microbial testing published by the independent Cannabis Safety Institute in 2015.22 The paper concluded that, although water activity is a useful metric, the four Aspergillus species in particular represent a significant health risk to immunocompromised individuals. Therefore, they should be screened for independently, and any samples that test positive should be rejected.California regulators seem to have taken this message to heart.16 Three different Aspergillus testing options are available to labs: Live culture of the entire genus26; polymerase chain reaction (PCR), a genomic test that hunts for the DNA of the target strains; and the latest method, quantitative PCR, which can not only detect but also quantify mold spores and cell fragments.The state does not stipulate which method should be used, says Bureau of Cannabis Control spokesman Aaron Francis—and the result, ultimately, is even more uncertainty about test results. That’s because the differences among the methods are not purely academic. Although the PCR-based genomic methods are faster and more precise, they also come with drawbacks.Most importantly, says Roy Upton, president of the American Herbal Pharmacopoeia (AHP) and lead editor of its 2013 cannabis monograph,27 molecular techniques may not always distinguish between living and dead microbes and thus may detect nonviable pathogens. Standard plating remains a reliable technique widely used in microbiological testing.The time-tested method of generating plate counts, however, has an Achilles’ heel of its own: There is no way to grow only the targeted species in a culture. Instead, a trained mycologist must be able to identify them by eye among the many other species that may be present.That’s exactly how it’s been done in the industry, says Josh Wurzer, president of the cannabis-testing lab SC Labs, which serves both California and Oregon, and itself has transitioned to using genomic methods of testing for microbial contaminants. “You can, and 20 years ago you had to, identify and count specific species using culture-based methods. I'm assuming some labs may [still] be doing that,” Wurzer says. “The drawbacks would be misidentification of the target species, causing either false positives or false negatives.”Like Oregon, Massachusetts does not require any specific tests for Aspergillus. But instead of relying on water activity as a proxy for microbial contamination, its Cannabis Control Commission has taken a third approach: testing for total yeast and mold counts using classic plate-based culture assays.17 Hudalla of ProVerde Laboratories acknowledges that this method cannot distinguish harmless microbes from potential threats and may lead to the rejection of perfectly safe cannabis flower. But he also argues that failed flower can be remediated through extraction and then resold in concentrated form—and that because total yeast and mold counts cover a broader range of potentially harmful microbes, they are also more protective of public health.Aspergillus is not the only point of contention when it comes to microbial testing. There’s also disagreement among states regarding the value of hunting for the pathogenic bacteria Salmonella and Escherichia coli as well as for mycotoxins28—toxic and carcinogenic compounds produced by the spores of certain molds (including Aspergillus) that are costly to test for and rarely encountered, says Susan Audino, a consultant who chairs the Cannabis Advisory Panel and Working Group of the Association of Official Analytical Chemists (AOAC). The AOAC and AHP are both currently working to bring some clarity to the matter of microbiological contamination of cannabis. They seek to develop new sets of standards and best practices to help guide regulators and the industry toward a more cohesive, empirical, and science-based approach.Getting there will take time, but for many in the industry it cannot happen soon enough, says Audino. “The challenge we have right now is that we are struggling to keep up with the stakeholder needs.” Meanwhile, she adds, “I think it is important to highlight the necessity to derive regulations based on science, and not base them on instrument capability.”
Authors: Laura M Dryburgh; Nanthi S Bolan; Christopher P L Grof; Peter Galettis; Jennifer Schneider; Catherine J Lucas; Jennifer H Martin Journal: Br J Clin Pharmacol Date: 2018-08-01 Impact factor: 4.335
Authors: Di Zhao; Ana Navas-Acien; Vesna Ilievski; Vesna Slavkovich; Pablo Olmedo; Bernat Adria-Mora; Arce Domingo-Relloso; Angela Aherrera; Norman J Kleiman; Ana M Rule; Markus Hilpert Journal: Environ Res Date: 2019-04-22 Impact factor: 6.498
Authors: Pablo Olmedo; Walter Goessler; Stefan Tanda; Maria Grau-Perez; Stephanie Jarmul; Angela Aherrera; Rui Chen; Markus Hilpert; Joanna E Cohen; Ana Navas-Acien; Ana M Rule Journal: Environ Health Perspect Date: 2018-02-21 Impact factor: 9.031
Authors: Dorina V Pinkhasova; Laura E Jameson; Kendra D Conrow; Michael P Simeone; Allan Peter Davis; Thomas C Wiegers; Carolyn J Mattingly; Maxwell C K Leung Journal: Curr Res Toxicol Date: 2021-03-01
Authors: Laura E Jameson; Kendra D Conrow; Dorina V Pinkhasova; Haleigh L Boulanger; Hyunji Ha; Negar Jourabchian; Steven A Johnson; Michael P Simeone; Iniobong A Afia; Thomas M Cahill; Cindy S Orser; Maxwell C K Leung Journal: Environ Health Perspect Date: 2022-09-14 Impact factor: 11.035
Authors: Simon Haroutounian; Lars Arendt-Nielsen; Joletta Belton; Fiona M Blyth; Louisa Degenhardt; Marta Di Forti; Christopher Eccleston; David P Finn; Nanna B Finnerup; Emma Fisher; Alexandra E Fogarty; Ian Gilron; Andrea G Hohmann; Eija Kalso; Elliot Krane; Mohammed Mohiuddin; R Andrew Moore; Michael Rowbotham; Nadia Soliman; Mark Wallace; Nantthasorn Zinboonyahgoon; Andrew S C Rice Journal: Pain Date: 2021-07-01 Impact factor: 6.961